Anhui Heryi Pharmaceutical Co (BJSE:920478) Moat Score: 0/10 (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920478 Anhui Heryi Pharmaceutical Co Ltd BJSE:920478
77 GF Score
Price ¥12.30
GF Value ¥10.49
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Anhui Heryi Pharmaceutical Co Moat Score?

Anhui Heryi Pharmaceutical Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Anhui Heryi Pharmaceutical Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Anhui Heryi Pharmaceutical Co might have No Moat - No discernible moat.

Anhui Heryi Pharmaceutical Co  (BJSE:920478) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Anhui Heryi Pharmaceutical Co Moat Score Related Terms

BJSE:920478
77GF Score
Anhui Heryi Pharmaceutical Co Ltd BJSE:920478
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Anhui Heryi Pharmaceutical Co (BJSE:920478) Overvalued in 2026?

Based on GuruFocus' analysis, Anhui Heryi Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥12.30 is trading 17.3% above its estimated GF Value™ of ¥10.49. GuruFocus considers Anhui Heryi Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for BJSE:920478:

  • Moat Score: 0
  • GF Value™: ¥10.49 vs. price of ¥12.30 (17.3% above fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the BJSE:920478 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Anhui Heryi Pharmaceutical Co Business Description

Address Yangcun Industrial Park, Anhui Province, Tianchang City, CHN, 239304
Anhui Heryi Pharmaceutical Co Ltd engages in research and development, production, and sales of pharmaceutical intermediates, raw materials, and related products. The main product categories include anti-allergy, anti-thrombosis, anti-oxidation, gastric ulcer, anti-virus, antipyretic and analgesic, and ultraviolet absorbent.
77GF Score

Get the complete analysis for BJSE:920478

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.30
Price
¥10.49
GF Value